Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2009 3
2010 1
2011 3
2012 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
A microRNA signature of hypoxia.
Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, Davuluri R, Liu CG, Croce CM, Negrini M, Calin GA, Ivan M. Kulshreshtha R, et al. Mol Cell Biol. 2007 Mar;27(5):1859-67. doi: 10.1128/MCB.01395-06. Epub 2006 Dec 28. Mol Cell Biol. 2007. PMID: 17194750 Free PMC article.
EphB6 receptor modulates micro RNA profile of breast carcinoma cells.
Bhushan L, Kandpal RP. Bhushan L, et al. PLoS One. 2011;6(7):e22484. doi: 10.1371/journal.pone.0022484. Epub 2011 Jul 19. PLoS One. 2011. PMID: 21811619 Free PMC article.
Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells.
Ichikawa T, Sato F, Terasawa K, Tsuchiya S, Toi M, Tsujimoto G, Shimizu K. Ichikawa T, et al. PLoS One. 2012;7(2):e31422. doi: 10.1371/journal.pone.0031422. Epub 2012 Feb 27. PLoS One. 2012. PMID: 22384020 Free PMC article.
miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase.
Song L, Lin C, Wu Z, Gong H, Zeng Y, Wu J, Li M, Li J. Song L, et al. PLoS One. 2011;6(9):e25454. doi: 10.1371/journal.pone.0025454. Epub 2011 Sep 27. PLoS One. 2011. PMID: 21980462 Free PMC article.
Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a.
Lin H, Dai T, Xiong H, Zhao X, Chen X, Yu C, Li J, Wang X, Song L. Lin H, et al. PLoS One. 2010 Dec 23;5(12):e15797. doi: 10.1371/journal.pone.0015797. PLoS One. 2010. PMID: 21203424 Free PMC article.
An integrative genomic analysis revealed the relevance of microRNA and gene expression for drug-resistance in human breast cancer cells.
Yamamoto Y, Yoshioka Y, Minoura K, Takahashi RU, Takeshita F, Taya T, Horii R, Fukuoka Y, Kato T, Kosaka N, Ochiya T. Yamamoto Y, et al. Mol Cancer. 2011 Nov 3;10:135. doi: 10.1186/1476-4598-10-135. Mol Cancer. 2011. PMID: 22051041 Free PMC article.
MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.
Lowery AJ, Miller N, Devaney A, McNeill RE, Davoren PA, Lemetre C, Benes V, Schmidt S, Blake J, Ball G, Kerin MJ. Lowery AJ, et al. Breast Cancer Res. 2009;11(3):R27. doi: 10.1186/bcr2257. Epub 2009 May 11. Breast Cancer Res. 2009. PMID: 19432961 Free PMC article.
MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells.
Pan YZ, Morris ME, Yu AM. Pan YZ, et al. Mol Pharmacol. 2009 Jun;75(6):1374-9. doi: 10.1124/mol.108.054163. Epub 2009 Mar 6. Mol Pharmacol. 2009. PMID: 19270061 Free PMC article.
Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth.
Maillot G, Lacroix-Triki M, Pierredon S, Gratadou L, Schmidt S, Bénès V, Roché H, Dalenc F, Auboeuf D, Millevoi S, Vagner S. Maillot G, et al. Cancer Res. 2009 Nov 1;69(21):8332-40. doi: 10.1158/0008-5472.CAN-09-2206. Epub 2009 Oct 13. Cancer Res. 2009. PMID: 19826037 Free article. Clinical Trial.